ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging

Rathan M. Subramaniam, Warren R. Janowitz, Geoffrey B. Johnson, Martin A. Lodge, Marguerite T. Parisi, Mark R. Ferguson, Jeffrey C. Hellinger, Gregory W. Gladish, Narainder K. Gupta

Research output: Contribution to journalArticle

2 Scopus citations


This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.

Original languageEnglish (US)
Pages (from-to)918-927
Number of pages10
JournalClinical Nuclear Medicine
Issue number12
Publication statusPublished - Dec 1 2017



  • ACR practice parameter
  • Cardiac PET/CT
  • Myocardial flow reserve
  • Sarcoid
  • Viability

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this